Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals Inc (IMLFF)

Inmed Pharmaceuticals Inc (IMLFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1851 +11.13%
on 10/15/19
0.2654 -22.49%
on 09/24/19
-0.0477 (-18.82%)
since 09/17/19
3-Month
0.1648 +24.82%
on 08/27/19
0.3360 -38.78%
on 09/10/19
-0.0463 (-18.37%)
since 07/17/19
52-Week
0.1648 +24.82%
on 08/27/19
0.6270 -67.19%
on 02/05/19
-0.3582 (-63.52%)
since 10/17/18

Most Recent Stories

More News
OTC Markets Group Announces Quarterly Index Performance and Rebalancing

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the third quarter 2019 performance and quarterly rebalancing of the OTCQX® and...

CAS : 0.41 (-18.00%)
CLABF : 0.3690 (-14.31%)
CTAM : 2.3000 (-8.00%)
FFNTF : 0.4400 (-4.31%)
OSTBP : 11.0000 (+10.00%)
BNPQF : 52.2700 (+0.52%)
CSVI : 44.0000 (unch)
IESFY : 139.3000 (+5.53%)
CBAF : 31.0000 (+1.97%)
CBKM : 18.3500 (+0.44%)
CCNB : 7.9200 (-0.50%)
CFNB : 17.1801 (-2.61%)
CPKF : 22.8300 (-1.59%)
DMKBA : 26.5000 (unch)
GNRV : 6.2000 (unch)
HLAN : 85.4300 (+1.95%)
MNBP : 385.0000 (-1.28%)
MVLY : 14.1000 (+0.71%)
OCBI : 27.7000 (unch)
PMHG : 20.0100 (unch)
PSBQ : 26.9900 (+3.57%)
TYCB : 34.7500 (+0.72%)
TYFG : 40.2500 (+0.32%)
UNIF : 8.5500 (-0.58%)
ABAHF : 4.2497 (-3.93%)
BCEKF : 1.6300 (unch)
CCHWF : 3.0450 (-0.81%)
ROGFF : 0.7200 (-1.76%)
AUSAF : 0.4700 (unch)
DXBRF : 0.3695 (+0.96%)
EEVVF : 0.1674 (+7.58%)
GTBIF : 9.6400 (+3.65%)
IMLFF : 0.2070 (-0.43%)
MDCL : 3.4700 (+0.58%)
TCNNF : 10.1536 (+0.43%)
VGWCF : 2.4900 (+3.49%)
OTCM : 34.3500 (-2.64%)
InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference

InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade...

IMLFF : 0.2070 (-0.43%)
InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference

VANCOUVER , Sept. 23, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing...

IMLFF : 0.2070 (-0.43%)
IN.TO : 0.26 (unch)
InMed Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / September 19, 2019 / InMed Pharmaceuticals, Inc. (TSX:) will be discussing their earnings results in their 2019 Fourth Quarter Earnings to be held on September 19, 2019 at 10:00...

IMLFF : 0.2070 (-0.43%)
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update

TSX:IN OTCQX:IMLFF

IMLFF : 0.2070 (-0.43%)
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update

TSX:IN OTCQX:IMLFF

IMLFF : 0.2070 (-0.43%)
IN.TO : 0.26 (unch)
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019

TSX:IN OTCQX:IMLFF

IMLFF : 0.2070 (-0.43%)
IN.TO : 0.26 (unch)
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019

TSX:IN OTCQX:IMLFF

IMLFF : 0.2070 (-0.43%)
InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Martin Bott steps down from the Board of Directors

IMLFF : 0.2070 (-0.43%)
InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Martin Bott steps down from the Board of Directors

IMLFF : 0.2070 (-0.43%)
IN.TO : 0.26 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade IMLFF with:

Key Turning Points

2nd Resistance Point 0.2430
1st Resistance Point 0.2254
Last Price 0.2070
1st Support Level 0.1909
2nd Support Level 0.1740

See More

52-Week High 0.6270
Fibonacci 61.8% 0.4504
Fibonacci 50% 0.3959
Fibonacci 38.2% 0.3414
Last Price 0.2070
52-Week Low 0.1648

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar